Greg McCartney's Colleagues at CNA Diagnostics Inc.
Greg McCartney's Contact Details
N/A
Surrey, British Columbia, Canada
CNA Diagnostics Inc.
Greg McCartney's Company Details
CNAD is currently developing rapid and cost-effective molecular testing systems for major bovine diseases. When animals contract diseases such as Bovine Spongiform Encephalopathy, Johne's disease or Bovine Respiratory disease, their body responds to the stress by releasing exosomes containing specific DNA molecules into the blood. This disease-specific process begins in the early stages of chronic diseases, often before any clinical signs can be observed. We expect that through the application of CNAD's molecular diagnostic technology, which is based on the detection of these specific DNA sequences, animals carrying diseases critical to the industry can be identified much earlier than currently possible (before the first clinical signs), and with better sensitivity and specificity. It is our goal to significantly improve the food safety for consumers, while increasing profitability for the livestock industry at the same time.